News & Updates

A dietary pattern with increased glycaemic index (GI) and load (GL) appears to elevate the risk of death due to cardiovascular diseases (CVDs), suggests a study involving Chinese adults.

A retrospective cross-sectional analysis of trends in glucose-lowering drug (GLD) use and glycaemic outcomes among Hong Kong’s 0.9 million adults with diabetes between 2002 and 2019 finds a levelling off in improvements since 2014.

In patients with severe obesity, undergoing either laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (RYGB) resulted in weight loss, according to long-term follow-up of the SLEEVEPASS* trial. However, remission of hypertension was more likely in patients who underwent RYGB compared with LSG.

A recent meta-analysis has confirmed the association of a proinflammatory diet with an increased risk of breast cancer, particularly among women who are obese, postmenopausal, and living in developing countries.

Patients with type 2 diabetes mellitus (T2DM) taking sodium-glucose cotransporter 2 inhibitors (SGLT2is) are less likely to be prescribed antigout or antihyperuricaemic drugs, a recent study has found.

In patients with type 2 diabetes (T2D) with chronic kidney disease (CKD), once-weekly dosage with dulaglutide achieves adequate glycaemic control along with a reduced decline in estimated glomerular filtration rate (eGFR), reports a recent study.

Communicating the risks of type 2 diabetes needs to be done in an emotionally impactful way while also having an interpersonal appeal, according to a recent Singapore study. To improve the uptake of healthy lifestyle practices, shifting from a long-term view of the disease to more short-term, observable benefits may be valuable.